BHS webinar supported by Astra Zeneca

PROGRAMME

Precision Medicine in CLL: a patient-centric approach to maximizing outcomes

19:00-19:05: Introduction (Prof Ann Janssens, UZ Leuven)

19:05-19:30: The role of biomarkers and patient preferences in treatment decisions (Dr Othman Al-Sawaf, Uniklinik Köln)

19:30-19:40: Treatments only work when taken: how to personalize follow-up care for CLL patients (Tine Van Nieuwenhuyse, pharmacist UZ Leuven)

19:40-20:00: Panel discussion (Dr Kirsten Saevels (UZA), Tine Van Nieuwenhuyse, Dr Othman Al-Sawaf, moderated by Prof Ann Janssens)